BI 691751

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

Safety of Single Rising Doses and Relative Bioavailability of BI 691751

CompletedNCT01843972

Boehringer IngelheimHealthy

Start: 2013-04-30End: 2013-11-30Updated: 2016-06-27

Interaction of BI 691751 With Itraconazole

CompletedNCT02044393

Boehringer IngelheimHealthy

Start: 2014-01-31End: 2014-05-31Updated: 2015-12-16

Multiple Rising Oral Doses of BI 691751 in Healthy Male Subjects

TerminatedNCT02148107

Boehringer IngelheimHealthy

Start: 2014-05-31End: 2014-08-31Updated: 2016-02-29